Biomarkers of hand osteoarthritis
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, přehledy
Grantová podpora
00023728
Project (Ministry of Health, Czech Republic) for conceptual development of research organization
260 373
Research project SVV
PubMed
29098370
DOI
10.1007/s00296-017-3864-5
PII: 10.1007/s00296-017-3864-5
Knihovny.cz E-zdroje
- Klíčová slova
- Biomarker, C-terminal cross-linking telopeptide, Cartilage oligomeric matrix protein, Hand osteoarthritis, Hyaluronan,
- MeSH
- adipokiny metabolismus MeSH
- biologické markery metabolismus MeSH
- chrupavka metabolismus patofyziologie MeSH
- klouby ruky metabolismus patofyziologie MeSH
- kosti ruky metabolismus patofyziologie MeSH
- lidé MeSH
- mediátory zánětu metabolismus MeSH
- obezita metabolismus patofyziologie MeSH
- osteoartróza diagnóza metabolismus patofyziologie MeSH
- prediktivní hodnota testů MeSH
- prognóza MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- adipokiny MeSH
- biologické markery MeSH
- mediátory zánětu MeSH
Hand osteoarthritis (OA) is a common degenerative joint disorder leading to substantial pain and disability. The most severe subtype is erosive hand OA characterized by an abrupt onset, local inflammation, subchondral erosions and worse outcomes than non-erosive disease. Biomarkers of hand OA could help to diagnose the disease earlier, to distinguish patients with erosive and non-erosive forms, to assess disease severity or to predict its future progression. The objective of this review was to summarize the role of potential biomarkers of hand OA. A PubMed search for soluble biomarkers associated with hand OA was performed from inception to June 2017. In total, 21 relevant publications were found and reviewed. These publications identified 20 potential biomarkers of hand OA. C-terminal cross-linking telopeptide of type II collagen, cartilage oligomeric matrix protein, osteocalcin, hyaluronan, urinary pentosidine, vascular cell adhesion molecule 1, monocyte chemotactic protein 1, osteoprotegerin and interleukin 1 have been shown as potential biomarkers for assessing disease severity. C-terminal cross-linking telopeptide of type I collagen, hyaluronan, urinary pentosidine and myeloperoxidase were shown to differentiate between erosive and non-erosive hand OA patients. A number of biomarkers reflecting joint tissue metabolism and inflammation have been studied in hand OA. Some were identified as potential biomarkers of disease severity and progression, others were shown to differentiate between erosive and non-erosive disease. However, further research is necessary to assess the value of biomarkers for use in clinical practice.
Department of Rheumatology 1st Faculty of Medicine Charles University Prague Czech Republic
Institute of Rheumatology Na Slupi 4 12850 Prague 2 Czech Republic
Zobrazit více v PubMed
Nat Rev Rheumatol. 2011 Jan;7(1):33-42 PubMed
Int J Biochem Cell Biol. 2009 May;41(5):998-1001 PubMed
Clin Pharmacol Ther. 2001 Mar;69(3):89-95 PubMed
J Biol Chem. 1998 Aug 7;273(32):20397-403 PubMed
Osteoarthritis Cartilage. 2006 Aug;14 (8):723-7 PubMed
Biochim Biophys Acta. 2006 Aug;1762(8):711-8 PubMed
Osteoarthritis Cartilage. 2009 Dec;17 (12 ):1615-9 PubMed
Osteoarthritis Cartilage. 2016 Jan;24(1):9-20 PubMed
J Biol Chem. 1997 Apr 11;272(15):9755-63 PubMed
J Orthop Res. 2007 Sep;25(9):1128-35 PubMed
J Biol Chem. 1990 Jun 25;265(18):10334-9 PubMed
Osteoarthritis Cartilage. 2004 Apr;12 (4):277-83 PubMed
Rheumatology (Oxford). 2016 Sep;55(9):1585-93 PubMed
J Biol Chem. 2007 Aug 24;282(34):24591-8 PubMed
Cell. 2007 Aug 10;130(3):456-69 PubMed
Arthritis Rheum. 2011 Nov;63(11):3383-91 PubMed
Cell. 1997 Apr 18;89(2):309-19 PubMed
FEBS Lett. 1994 Nov 7;354(2):237-40 PubMed
Ann Rheum Dis. 2014 Feb;73(2):365-75 PubMed
Osteoarthritis Cartilage. 2005 Mar;13(3):258-65 PubMed
Osteoarthritis Cartilage. 2001 Nov;9(8):720-6 PubMed
J Biol Chem. 2001 Feb 23;276(8):6046-55 PubMed
J Biol Chem. 2011 Dec 16;286(50):43250-8 PubMed
Ann Rheum Dis. 2011 Jul;70(7):1282-4 PubMed
J Orthop Traumatol. 2008 Jun;9(2):81-7 PubMed
J Hum Genet. 2003;48(5):222-5 PubMed
J Intern Med. 1997 Jul;242(1):27-33 PubMed
Osteoarthritis Cartilage. 2006 Jul;14(7):690-5 PubMed
Arthritis Rheum. 1999 May;42(5):1003-9 PubMed
Joint Bone Spine. 2012 Mar;79(2):160-5 PubMed
Int J Tissue React. 2003;25(1):25-8 PubMed
Curr Opin Rheumatol. 2013 Jan;25(1):136-44 PubMed
Arch Biochem Biophys. 1997 May 1;341(1):8-16 PubMed
Mol Biol Rep. 2010 Oct;37(7):3265-72 PubMed
Ann Rheum Dis. 2005 Jun;64(6):955-7 PubMed
J Biol Chem. 1992 Nov 5;267(31):22346-50 PubMed
J Biol Chem. 2005 Sep 23;280(38):32655-61 PubMed
J Biol Chem. 2007 Oct 26;282(43):31166-73 PubMed
Osteoarthritis Cartilage. 2008 Sep;16(9):1054-9 PubMed
J Biol Chem. 1978 Dec 25;253(24):9063-8 PubMed
Arthritis Rheum. 2001 May;44(5):985-94 PubMed
Clin Exp Rheumatol. 2011 May-Jun;29(3):544-6 PubMed
Curr Genomics. 2015 Dec;16(6):419-26 PubMed
Proc Natl Acad Sci U S A. 1976 May;73(5):1447-51 PubMed
J Immunol Methods. 2004 Nov;294(1-2):145-53 PubMed
Osteoarthritis Cartilage. 2012 Jun;20(6):557-61 PubMed
Ann Rheum Dis. 2009 Jan;68(1):8-17 PubMed
Arthritis Rheum. 1999 Jul;42(7):1443-50 PubMed
Arthritis Rheum. 1999 Mar;42(3):483-9 PubMed
Cell. 2011 Mar 4;144(5):796-809 PubMed
Arthritis Rheum. 2010 Jul;62(7):1993-2003 PubMed
J Cell Biol. 1991 Sep;114(6):1307-19 PubMed
Physiol Res. 2002;51(2):139-44 PubMed
J Rheumatol. 2014 May;41(5):938-44 PubMed
J Biol Chem. 1980 Sep 25;255(18):8685-91 PubMed
Ann Rheum Dis. 2017 Jan;76(1):214-217 PubMed
Bone. 2001 Sep;29(3):209-15 PubMed
J Clin Invest. 1997 Apr 1;99(7):1534-45 PubMed
Osteoarthritis Cartilage. 2016 Apr;24(4):573-80 PubMed
Eur J Appl Physiol Occup Physiol. 1998 Nov;78(6):573-7 PubMed
J Biol Chem. 1976 Mar 10;251(5):1371-4 PubMed
Ann Rheum Dis. 2005 May;64(5):682-7 PubMed
Ann Rheum Dis. 2013 Nov;72(11):1756-63 PubMed
Osteoarthritis Cartilage. 2010 Nov;18(11):1448-53 PubMed
Proc Natl Acad Sci U S A. 1980 Apr;77(4):2234-8 PubMed
Nat Rev Rheumatol. 2016 May;12(5):296-302 PubMed
Am J Epidemiol. 2002 Dec 1;156(11):1021-7 PubMed
Ann Rheum Dis. 2009 Feb;68(2):295-6 PubMed
Br J Rheumatol. 1997 Nov;36(11):1151-60 PubMed
Am J Hum Genet. 1998 Feb;62(2):311-9 PubMed
J Biol Chem. 2000 Nov 3;275(44):34681-92 PubMed
Rheumatology (Oxford). 2016 Apr;55(4):680-8 PubMed
Ann Rheum Dis. 2006 Mar;65(3):360-5 PubMed
Arthritis Res Ther. 2011;13(6):R184 PubMed
Rheumatol Int. 2010 Jun;30(8):1131-5 PubMed
Clin Exp Rheumatol. 2016 Nov-Dec;34(6):991-998 PubMed
Clin Chem. 1994 Nov;40(11 Pt 1):2022-5 PubMed
Rheumatology (Oxford). 2013 Feb;52(2):400-2 PubMed
J Biol Chem. 1992 Mar 25;267(9):6132-6 PubMed
Osteoarthritis Cartilage. 2007 May;15(5):516-23 PubMed
Open Rheumatol J. 2012;6:64-9 PubMed
PLoS One. 2012;7(10 ):e47860 PubMed
Mediators Inflamm. 2009;2009:345838 PubMed
Osteoarthritis Cartilage. 2004 Oct;12(10):843-5 PubMed
J Bone Miner Res. 1997 Jul;12(7):1028-34 PubMed
Nature. 1996 Aug 1;382(6590):448-52 PubMed
Dev Dyn. 1995 Jun;203(2):198-211 PubMed
Ann Rheum Dis. 1994 Jan;53(1):8-13 PubMed